Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Truist Securities maintains Buy rating on Viking Therapeutics, $87 price target
Truist Securities maintained their Buy rating on Viking Therapeutics's stock with a price target of $87.00.The price target implies an upside of 113.0% from the Sep 22 close of $40.85.Key takeaways from the analyst noteStrong Clinical Pipeline: Viking Therapeutics boasts a robust clinical program w…